Neuropsychopharmacology
- Applications of functional neurotransmitter release imaging with genetically encoded sensors in psychiatric research2 years ago
- VTA glutamatergic projections to the nucleus accumbens suppress psychostimulant-seeking behavior2 years ago
- Ketamine reduces the neural distinction between self- and other-produced affective touch: a randomized double-blind placebo-controlled study2 years ago
- Cross-ancestry genetic investigation of schizophrenia, cannabis use disorder, and tobacco smoking2 years ago
- A review of diffusion MRI in mood disorders: mechanisms and predictors of treatment response2 years ago
- Quality over quantity: powering neuroimaging samples in psychiatry2 years ago
- Racial and ethnic socioenvironmental inequity and neuroimaging in psychiatry: a brief review of the past and recommendations for the future2 years ago
Journal of Psychopharmacology
- Clinical effects of glabellar botulinum toxin injections on borderline personality disorder: A randomized controlled trial4 years ago
- Development and validation of the Reward Deficiency Syndrome Questionnaire (RDSQ-29)4 years ago
- The neuropeptide cycloprolylglycine produces antidepressant-like effect and enhances BDNF gene expression in the mice cortex4 years ago
- Comparative safety of chronic versus intermittent benzodiazepine prescribing in older adults: A population-based cohort study4 years ago
- Modulation of microglial activation by antidepressants4 years ago
- Refractory delirium tremens treated with ketamine5 years ago
- A phase 1 study to assess potential interaction between ASP8062 and alcohol in healthy adult subjects5 years ago
European Neuropsychopharmacology
- Requiem or resurrection: Classic monoamine oxidase inhibitors revisited4 years ago
- A double-blind, randomized, placebo-controlled proof of concept study of the efficacy and safety of Lu AF11167 for persistent negative symptoms in people with schizophrenia4 years ago
- Digital tools for the assessment of pharmacological treatment for depressive disorder: State of the art4 years ago
- A pacemaker for happiness – Transcutaneous vagus nerve stimulation in depression4 years ago
- Expert consensus recommendations on the use of randomized clinical trials for drug approval in psychiatry- comparing trial designs4 years ago
- Corrigendum to “34th ECNP Congress – Lisbon 2021 Hybrid. [34th ECNP Congress – Lisbon 2021 Hybrid. 53S1. December 2021]” P.0576 Knockdown of 5-HT1A receptor silencer Freud-2 in the frontal cortex affected the behavior and the serotonin system in mice4 years ago
- Transcriptome meta-analysis of valproic acid exposure in human embryonic stem cells4 years ago